Liu et al. demonstrated that the upregulation of MCU is associated with poor prognosis in colorectal cancer (CRC) patients, and MCU promotes mitochondrial Ca2+ uptake to enhance dephosphorylation of mitochondrial transcription factor A (TFAM), leading to mitochondrial biogenesis in CRC [24]. This evidence concerns the gene MCU and colorectal cancer.